LexDanaLexDanabeta
Inventor

FRANCOISE PERRON-SIERRA

Inventor
FR

Overview

2→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
C07JSteroids50%
PatentTitleYear
11,807,659TGR5 modulators and methods of use thereof202311,345,721TGR5 modulators and methods of use thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to INTERCEPT PHARMACEUTICALS INC (2)· patent assignee history
2022–2023Based in FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INTERCEPT PHARMACEUTICALS INC22022–2023
Locations
LocationPatentsSpan
FR22022–2023